ITP Innovative Tomography Products GmbH

ITP Innovative Tomography Products GmbH specialises in biopsy-related devices, including semi-automatic biopsy needle handpieces (such as the BIM 18/10 or BIM 16/20) and coaxial interventional needles. These are designed for tissue sampling and controlled interventional procedures in medical diagnostics. The company also produces single-use hypodermic needles, which are essential for sterile, repeatable sampling in clinical settings.

ITP Innovative Tomography Products GmbH is based in Germany, which means its devices must comply with EU Medical Device Regulations (MDR) or the Medical Device Directive (MDD) depending on the applicable timeline. Since the company’s products are listed in eudamed, they are registered under EU regulatory frameworks. Classification under Class I or Class II/IIa determines the specific authorisation requirements for market placement in the EU.

ITP Innovative Tomography Products GmbH’s devices are registered in eudamed (the EU’s medical device database), the FDA’s 510(k) premarket notification system, and the FDA’s Unique Device Identifier (UDI) registry. This visibility ensures transparency for regulators and healthcare providers, facilitating compliance verification, traceability, and market surveillance. Listing in these systems also supports post-market monitoring and recalls if needed.

Under EU regulations, ITP’s devices fall into Class I (low-risk, often exempt from full conformity assessment) or Class II/IIa (moderate-risk, requiring additional scrutiny such as clinical evaluation or notified body involvement). In the US, classification aligns with FDA’s risk-based system, where similar devices would typically undergo 510(k) premarket notification to demonstrate substantial equivalence to existing cleared products. The exact classification determines the regulatory pathway for market authorisation.